The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis
Open accessAbstract
Hemophagocytic lymphohistiocytosis is a hyperinflammatory syndrome defined by clinical and laboratory criteria. Current criteria were created to identify patients with familial hemophagocytic lmyphohistiocytosis in immediate need of immunosuppressive therapy. However, these criteria also identify patients with infection-associated hemophagocytic inflammatory states lacking genetic defects typically predisposing to hemophagocytic lymphohistiocytosis. These patients include those with primary immunodeficiencies, in whom the pathogenesis of the inflammatory syndrome may be distinctive and aggressive immunosuppression is contraindicated. To better characterize hemophagocytic inflammation associated with immunodeficiencies, we combined an international survey with a literature search and identified 63 patients with primary immunodeficiencies other than cytotoxicity defects or X-linked lymphoproliferative disorders, presenting with conditions fulfilling current criteria for hemophagocytic lymphohistiocytosis. Twelve patients had severe combined immunodeficiency with <100/μL T cells, 18 had partial T-cell deficiencies; episodes of hemophagocytic lymphohistiocytosis were mostly associated with viral infections. Twenty-two patients had chronic granulomatous disease with hemophagocytic episodes mainly associated with bacterial infections. Compared to patients with cytotoxicity defects, patients with T-cell deficiencies had lower levels of soluble CD25 and higher ferritin concentrations. Other criteria for hemophagocytoc lymphohistiocytosis were not discriminative. Thus: (i) a hemophagocytic inflammatory syndrome fulfilling criteria for hemophagocytic lymphohistiocytosis can be the initial manifestation of primary immunodeficiencies; (ii) this syndrome can develop despite severe deficiency of T and NK cells, implying that the pathophysiology is distinct and not appropriately described as "lympho"-histiocytosis in these patients; and (iii) current criteria for hemophagocytoc lymphohistiocytosis are insufficient to differentiate hemophagocytic inflammatory syndromes with different pathogeneses. This is important because of implications for therapy, in particular for protocols targeting T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Luca, A., Smeekens, S. P., Casagrande, A., Iannitti, R., Conway, K. L., Gresnigt, M. S., Begun, J., Plantinga, T. S., Joosten, L. A. B., van der Meer, J. W. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322831111 · Cited by 313
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab
Marsh, R. A., Allen, C. E., McClain, K. L., Weinstein, J. L., Kanter, J., Skiles, J., Lee, N. D., Khan, S. P., Lawrence, J., Mo, J. Q., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24188 · Cited by 310
Self-citationHemophagocytic lymphohistiocytosis and primary immune deficiency disorders
Faitelson, Y., & Grunebaum, E. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.09.008 · Cited by 51
Cited by
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Emile, J.-F., Abla, O., Fraitag, S., Horne, A., Haroche, J., Donadieu, J., Requena-Caballero, L., Jordan, M. B., Abdel-Wahab, O., Allen, C. E., et al. (2016) · Blood · doi:10.1182/blood-2016-01-690636 · Cited by 1,591
Self-citationRecommendations for the management of hemophagocytic lymphohistiocytosis in adults
La Rosée, P., Horne, A., Hines, M., von Bahr Greenwood, T., Machowicz, R., Berliner, N., Birndt, S., Gil-Herrera, J., Girschikofsky, M., Jordan, M. B., et al. (2019) · Blood · doi:10.1182/blood.2018894618 · Cited by 1,108
Self-citationPediatric hemophagocytic lymphohistiocytosis
Canna, S. W., & Marsh, R. A. (2020) · Blood · doi:10.1182/blood.2019000936 · Cited by 496
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T.-D. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 438
Jordan, M. B., Allen, C. E., Greenberg, J., Henry, M., Hermiston, M. L., Kumar, A., Hines, M., Eckstein, O., Ladisch, S., Nichols, K. E., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27929 · Cited by 424
Self-citation
Metadata
- Authors
- Bode, S. F., Ammann, S., Al-Herz, W., Bataneant, M., Dvorak, C. C., Gehring, S., Gennery, A., Gilmour, K. C., Gonzalez-Granado, L. I., Gross-Wieltsch, U., Ifversen, M., Lingman-Framme, J., Matthes-Martin, S., Mesters, R., Meyts, I., van Montfrans, J. M., Schmid, J. P., Pai, S.-Y., Soler-Palacin, P., Schuermann, U., Schuster, V., Seidel, M. G., Speckmann, C., Stepensky, P., Sykora, K.-W., Tesi, B., Vraetz, T., Waruiru, C., Bryceson, Y. T., Moshous, D., Lehmberg, K., Jordan, M. B., Ehl, S., & for the Inborn Errors Working Party of the, E. B. M. T.
- Venue
- Haematologica
- Published
- 2015-05-28
- Volume
- 100
- Issue
- 7
- Pages
- 978-988
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2264495358
- Cited by
- 196
- References
- 3
- FWCI
- 13.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. https://app.cochat.ai/papers/10.3324/haematol.2014.121608
- The paper
- Bode, S. F., Ammann, S., Al-Herz, W., Bataneant, M., Dvorak, C. C., Gehring, S., Gennery, A., Gilmour, K. C., Gonzalez-Granado, L. I., Gross-Wieltsch, U., Ifversen, M., Lingman-Framme, J., Matthes-Martin, S., Mesters, R., Meyts, I., van Montfrans, J. M., Schmid, J. P., Pai, S.-Y., Soler-Palacin, P., . . . for the Inborn Errors Working Party of the, E. B. M. T. (2015). The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica. https://doi.org/10.3324/haematol.2014.121608
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.